2Narayan R,Buronfosse T,Schultz U,et al.Rise in gamma interferon expression during resolution of duck hepatitis B virus infection[J].J Gen Virol,2006,87(11):3225.
3Hsia CC,Purcell RH,Farshid M,et al.Quantification of hepatitis B virus genomes and infectivity in human serum samples[J].Transfusion,2006,46(10):1829.
5Daza P,Banda R,Misoya K,et al.The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi,a country with high human immunodeficiency virus prevalence[J].Vaccine,2006,24(37-39):6232.
6Kwon CH,Suh KS,Yi NJ,et al.Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation[J].Pediatr Transplant,2006,10(4):479.
7Martinot PM,Comanor L,Minor JM,et al.Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C[J].J Viral Hepat,2006,13(10):701.
8Itsui Y,Sakamoto N,Kurosaki M,et al.Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication[J].J Viral Hepat,2006,13(10):690.
9Munoz H,Arroyo J,Torres EA,et al.Response to combination therapy of interferon alfa-2b plus ribavirin in Hispanics with chronic hepatitis C[J].PR Health Sci J,2004,23(2S):61.
10Zheng S,Chen Y,Liang T,et al.Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis[J].Liver Transpl,2006,12(2):253.
